RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 6 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Requirements for Adaptive Designs in Clinical Trials

Requirements for Adaptive Designs in Clinical Trials

Posted 01 June 2009 | By

The interest in adaptive trial design has rapidly increased within the pharmaceutical industry in recent years. Furthermore, regulatory authorities are promoting adaptive design features in order to support "more efficient trial design," which was defined as one of the goals of the US Food and Drug Administration's Critical Path Initiative.1

Regulatory Focus newsletters

All the biggest regulatory news and happenings.